Zika Vaccines

The challenges in developing a safe and effective Zika virus vaccine include limiting side effects such as Guillain-Barré syndrome, a potential consequence of Zika virus infection. Discover the latest research on Zika vaccines here.

August 4, 2020
Open Access

Current Approaches and Trends in Graduate Public Health Informatics Education in the United States: Four Case Studies from the Field

Online Journal of Public Health Informatics
Diane G SchwartzBrian E Dixon
July 11, 2020
Open Access

Nanosensors based on LSPR are able to serologically differentiate dengue from Zika infections

Scientific Reports
Alice F VersianiFlávio G da Fonseca
August 2, 2020

Zika Virus-Like Particle (VLP) vaccine displaying Envelope (E) protein CD loop antigen elicits protective and specific immune response in a murine model

Biochemical and Biophysical Research Communications
Velasco CimicaTimothy T Stedman
August 5, 2020

Nanotechnology-based antiviral therapeutics

Drug Delivery and Translational Research
Malobika Chakravarty, Amisha Vora
July 6, 2020

Outcomes of subsequent pregnancies following Zika virus infection: A comparative case series

International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics
Adriana MeloMelania M Amorim
July 22, 2020
Open Access

Quantifying sociodemographic heterogeneities in the distribution of Aedes aegypti among California households

PLoS Neglected Tropical Diseases
Marisa A P DonnellyChristopher M Barker
July 24, 2020

Zika vaccine pre-clinical and clinical data review with perspectives on the future development

Human Vaccines & Immunotherapeutics
Stephen J Thomas, Alan Barrett
July 16, 2020
Open Access

24-hour Holter findings in infants with in-utero exposure to the Zika virus: a series of cases

Revista Do Instituto De Medicina Tropical De São Paulo
Dulce OrofinoRaquel de Vasconcellos Carvalhaes de Oliveira
July 15, 2020
Open Access

Experience of women with prenatal Zika virus infection who continued gestation in Colombia

Gaceta sanitaria
Celmira Laza-VásquezErica Briones-Vozmediano
July 4, 2020
Open Access

Gestational outcomes in women infected by Zika virus during pregnancy in Mato Grosso do Sul, Brazil: cross-sectional study

International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
Iara Beatriz Andrade de SousaSilvana Beutinger Marchioro
July 4, 2020

Intermolecular interactions of cn-716 and acyl-KR-aldehyde dipeptide inhibitors against Zika virus

Physical Chemistry Chemical Physics : PCCP
Daniel M O CamposJonas I N Oliveira
July 17, 2020
Open Access

Inhibition of Na+ /K+ ATPase blocks Zika virus infection in mice

Communications Biology
Jiao GuoWei Wang
July 10, 2020

Envelope protein ubiquitination drives entry and pathogenesis of Zika virus

Maria I GiraldoRicardo Rajsbaum
July 27, 2020

Modeling and Dynamics Analysis of Zika Transmission with Limited Medical Resources

Bulletin of Mathematical Biology
Hongyong ZhaoHuaiping Zhu
July 7, 2020
Open Access

Role of microglia in the dissemination of Zika virus from mother to fetal brain

PLoS Neglected Tropical Diseases
Pei XuPing Wu
July 6, 2020

Zika virus infection causes widespread damage to the inner ear

Hearing Research
Kathleen T YeeDouglas E Vetter

Sign up to follow this feed and discover related papers.

Related Feeds

AIDS Malignancies

HIV infection increases the risk of non-communicable diseases common in the aged, including cardiovascular disease, neurocognitive decline, non-aids malignancies, osteoporosis, and frailty. Discover the latest research in AIDS malignancies.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.


Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.


Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.


Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

© 2020 Meta ULC. All rights reserved